Related Experiment Video
Updated: Oct 29, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Atrial fibrillation is associated with increased central blood pressure and arterial stiffness
Priit Pauklin1,2, Jaan Eha1,2, Kaspar Tootsi3
1Department of Cardiology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Insights
Patients with atrial fibrillation (AF) exhibit increased arterial stiffness (AS) and central blood pressure (cBP). Beta blockers (BBs) may adversely affect central blood pressure in AF patients.
Area of Science:
- Cardiovascular Medicine
- Clinical Physiology
Background:
- Atrial fibrillation (AF) is a common arrhythmia managed with beta blockers (BBs).
- Arterial stiffness (AS) and central blood pressure (cBP) are crucial cardiovascular parameters.
- Understanding the interplay between AF, AS, cBP, and BBs is clinically significant.
Purpose of the Study:
- To compare arterial stiffness (AS) and central blood pressure (cBP) in patients with AF versus healthy individuals.
- To investigate the impact of beta blockers (BBs) on cBP in AF patients.
Main Methods:
- Carotid-femoral pulse wave velocity (PWV) and cBP were measured in 76 AF patients and 75 healthy controls.
- Peripheral blood pressure (pBP) and heart rate (HR) were also recorded.
- Statistical analysis, including adjusted regression models, was performed.
Main Results:
- AF patients demonstrated significantly higher PWV, central systolic blood pressure (cSBP), and central pulse pressure (cPP) compared to controls.
- AF patients exhibited lower pulse pressure amplification (PPA).
- Beta blocker (BB) use was associated with a significant reduction in PPA.
Conclusions:
- Increased arterial stiffness (AS) may play a role in the pathophysiology of atrial fibrillation (AF).
- AF patients present with distinct central hemodynamic profiles compared to healthy individuals.
- Beta blocker (BB) therapy might have implications for central blood pressure regulation in AF.
Abstract:
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and beta blockers (BBs) are the drugs of choice for rate or rhythm control in these patients. The purpose of this study was to describe differences in arterial stiffness (AS), central blood pressure (cBP), and the role of BBs on cBP in patients with AF compared to healthy individuals. The authors included 76 patients with paroxysmal/persistent AF. Carotid-femoral pulse wave velocity (PWV) and cBP were measured and compared with data from 75 healthy individuals. Patients with AF had higher PWV (8.0 m/s vs. 7.2 m/s, p < .001), central systolic blood pressure (cSBP) (118 mm Hg vs. 114 mm Hg, p = .033), central pulse pressure (cPP) (39 mm Hg vs. 37 mm Hg, p = .035) and lower pulse pressure amplification (PPA) (1.24 vs. 1.30, p = .015), without differences in peripheral blood pressure (pBP) and heart rate (HR). AF patients had significantly increased PWV (β= 0.500, p = .010, adjusted R² = 0.37) after adjustment for confounding factors. The use of BBs significantly reduced PPA (β = -0.059, p = .017, adjusted R² = 0.30). AF patients have higher PWV, cSBP, cPP, and lower PPA, compared to healthy patients. These findings support the role of AS in the development of AF. Use of BBs is related to a potential adverse effect on cBP.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Hypertension II: Pathophysiology
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Dysrhythmias II: Classification of Tachyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

